Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States. (2021)
Attributed to:
Centre for Global Infectious Disease Analysis, Imperial College London (GIDA) - COVID-19
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2021359118
PubMed Identifier: 33658331
Publication URI: http://europepmc.org/abstract/MED/33658331
Type: Journal Article/Review
Volume: 118
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 12
ISSN: 0027-8424